BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36104060)

  • 1. Prevalence of carbapenemase genes among multidrug-resistant
    Saengsuwan P; Kositpantawong N; Kawila S; Patugkaro W; Romyasamit C
    Saudi Med J; 2022 Sep; 43(9):991-999. PubMed ID: 36104060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand.
    Khuntayaporn P; Montakantikul P; Mootsikapun P; Thamlikitkul V; Chomnawang MT
    Ann Clin Microbiol Antimicrob; 2012 Sep; 11():25. PubMed ID: 22970983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
    Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
    Li J; Zou M; Dou Q; Hu Y; Wang H; Yan Q; Liu WE
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):35. PubMed ID: 27215335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular surveillance of carbapenemase-producing
    Schäfer E; Malecki M; Tellez-Castillo CJ; Pfennigwerth N; Marlinghaus L; Higgins PG; Mattner F; Wendel AF
    Antimicrob Resist Infect Control; 2019; 8():208. PubMed ID: 31893042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand.
    Khuntayaporn P; Montakantikul P; Santanirand P; Kiratisin P; Chomnawang MT
    Microbiol Immunol; 2013 Mar; 57(3):170-8. PubMed ID: 23278679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of Metallo-Beta-Lactamase and alginate in multidrug resistance
    Qader GM; Jarjees KK; Jarjees RK
    J Med Life; 2022 Sep; 15(9):1105-1109. PubMed ID: 36415531
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia.
    Vanegas JM; Cienfuegos AV; Ocampo AM; López L; del Corral H; Roncancio G; Sierra P; Echeverri-Toro L; Ospina S; Maldonado N; Robledo C; Restrepo A; Jiménez JN
    J Clin Microbiol; 2014 Nov; 52(11):3978-86. PubMed ID: 25210071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-Resistance Genes in Pseudomonas aeruginosa from Wound Infections in a Tertiary Health Institution in Osogbo, Nigeria.
    Akinloye AO; Adefioye JO; Adekunle CO; Anomneze BU; Makanjuola OB; Onaolapo OJ; Onaolapo AY; Olowe OA
    Infect Disord Drug Targets; 2021; 21(1):90-98. PubMed ID: 31957616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary.
    O'Neall D; Juhász E; Tóth Á; Urbán E; Szabó J; Melegh S; Katona K; Kristóf K
    Acta Microbiol Immunol Hung; 2020 Mar; 67(1):61-65. PubMed ID: 32208923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa.
    De Rosa A; Mutters NT; Mastroianni CM; Kaiser SJ; Günther F
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1547-1552. PubMed ID: 31152264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima.
    Kouda S; Ohara M; Onodera M; Fujiue Y; Sasaki M; Kohara T; Kashiyama S; Hayashida S; Harino T; Tsuji T; Itaha H; Gotoh N; Matsubara A; Usui T; Sugai M
    J Antimicrob Chemother; 2009 Jul; 64(1):46-51. PubMed ID: 19398456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital.
    Phoon HYP; Hussin H; Hussain BM; Thong KL
    Microb Drug Resist; 2018 Oct; 24(8):1108-1116. PubMed ID: 29437541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey.
    Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME
    Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the resistance mechanism and homology of carbapenems-resistant Pseudomonas aeruginosa].
    Liu Y; Deng Q; Yu Y; Cao X; Xu Q; Wan L
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):15-20. PubMed ID: 24684984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual diversity of acquired β-lactamases in multidrug-resistant Pseudomonas aeruginosa isolates in a Mexican hospital.
    Castillo-Vera J; Ribas-Aparicio RM; Nicolau CJ; Oliver A; Osorio-Carranza L; Aparicio-Ozores G
    Microb Drug Resist; 2012 Oct; 18(5):471-8. PubMed ID: 22554004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Gutiérrez O; Juan C; Cercenado E; Navarro F; Bouza E; Coll P; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4329-35. PubMed ID: 17938181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.